health I everyone, staying for Thanks, and times. are and hope safe good in thank today. you Ronnie. and these during challenging your Good uniquely families you us joining morning,
customers to safety pandemic and of our colleagues, impacts the COVID-XX health staff, and remains site the we all of protecting serve. on team the evolve, continue the our patients As focused
are of speed with a collaborating customers As develop health we and to without actively working care unparalleled this pandemic, battle and safety compromising part community requirements. multiple regulatory requires treatment global the vaccine. This to fight COVID-XX
reaching are help trials targeting standing this organizations accelerated challenging manage enrollment, to communications for communications everything for crisis up us from to out their time. Customers to to through
We all. also want clinically health professionals, Health are have work our Syneos qualified is been and we to care their ICU volunteers bravery thank who many fighting boldly the including grateful frontline bound, pandemic. for protect us own Their incredible, to the of
quarter culture of the challenging believe kept thank living change health during will we into exhibiting deliver our solutions to I'm team Syneos has our details, first status to which to sites and the sustain time. and incredibly collaborating and our to Lastly, collaborating their lives, advance quo, my strong. I We pandemic efforts the our all for beyond. before during with want public the community collective values our for strength this and customers, get commitment passion resilient and of colleagues proud Health this shared of
results. financial our to now Turning
are detail XXXX are seeing carried start how business. the the to of the impacts our strength position we market that the results, the discussing subside. trends by we the have today I saying our business to in of impacts XXXX COVID-XX to the some across will of expect After first The for the we it build and confident to addressing remain into take near-term time as COVID-XX long-term and and created. effects continue me the results over and quarter, that unique different we given Let strategy, despite momentum we backlog robust in and accelerate began in our our QX challenges, business
start me with let But first, key the quarter. our from highlights
of for first Clinical inclusive total awards ratio and trailing business X.Xx X.XXx quarter in new Solutions X.XXx an book-to-bill clinical, to Solutions, net resulting for for XX-month awards net and billion the Commercial X.XXx strong with book-to-bill a of our aggregate a of for for QX This record company. closed we of ratio $X.X us First, brings period.
continues strong X.X% growth business clinical performance our to Second, year-over-year constant in show currency. X.X% with or of
in Third, million credit we we remain of in At our revolving financial available the liquidity. $XXX confident and the facility. our position overall of capacity $XXX million had on quarter, and end cash
and We expect Jason further to which the financial cash capital preserve and more to have taken generate steps XXXX for remainder detail. proactive flexibility, will free flow of provide in describe
had Total solid in adjusted constant was the line especially the environment expectations. results. grew revenue changing of our into our a details considering X.X% macro quarter currency, which rapidly with overall, going or in We March. Now during X.X%
to and Solutions establish were first growth, continue broad-based strong awards we presence record relationships. in our ratio and of awards as awards, X.XXx period. provider XX quarter top clinical resulting Clinical a net to a addition delivered deepen In in of billion XX-month preferred book-to-bill for pharma the revenue a trailing These net our through $X.X total new of
of of flow customers. awards growing is share with benefits of one the consistency strategic pharma our This top
decisions segment awarded backlog Our XX.X%, we for new have pipeline start related some and to opportunities year-over-year customers accelerated our programs. of experience postponing did meaningful dates in We remains to or slowing cancellations clinical our seen COVID-XX, any not award robust. growth clinical although
lower-than-anticipated Commercial X.X% due revenue Solutions a to unfavorable and decline mix year, an of to compared the prior reimbursable segment experienced expenses. revenue primarily Our
these contemplated somewhat forecast. with relatively the offset of cancellations COVID-XX. cancellations, awards, team to strong the were finished our the Although which were revenue majority the in year unrelated were awards majority by full higher quarter The of
book-to-bill. year resulted the occur of for of expected, awards This the $X.X billion XX-month net X.XXx impacting did and a in period. book-to-bill earlier thus in trailing than they However,
increased some in opportunities RFP Our pipeline commercial and of volume. remains robust given customer decisions delays
As we health employees, colleagues of our COVID-specific to the and protecting industry in turn is safety our customers and commentary, paramount response.
ensuring well-established TMO, the which the all combines transition monitors employee management leadership. consistent Office and to and Our while Management safety and management transition manages seamless of discipline business This or group our response led Process performance. a by Transition remote our rapid with Business is project Continuity operations, Trusted
now COVID-XX response, several is more We and reopen and over phase facilities this appropriate. return when The to to is which planning in TMO anticipate normal. model, occur the safe field this that traditional in will be the in teams phases operating we a months, our next will our deploy ready our new
to protective continue government criteria. protocols focused office mandates. have we upon sourcing protocols to and personal and all cleaning prioritization establishing We also personnel In based appropriate staging the and will on meantime, with safety comply return equipment,
our also can by supported the the business health continuity, extended and address have actions employees communities. our In have fight addition response initiatives we help. public expertise we ensure decisive onset, to to and in talent our health acute against the local pandemic in engaging where public to have within needs local our the we taken protect communities From
examples. share me a few Let
across Firstly, airway medical and intubated machines public or ventilation to created the reduce the service BiPAP COVID-XX raise mechanical collaborative of for to a bi-level need communications educational positive initiative of pressure team use awareness patients. for
also practice to participate staff ACRO the COVID-XX collaboration time, And the to of Our adding with answered this during other members U.K. global staff medical call mentioned, also to the testing. enabled to increase level further we volunteers as the as pandemic in clinically-qualified response. strength our in
been energy and initiatives. to Syneos do within of employees and with has are people can that our The ready to the they of and proud of help passion very whatever a these part wave patients Health to our magnified teams are be solution. We
impacts of context, would responding. helpful the broader we are some to detail be thought I how we are it that experiencing and With
areas of segment, representing such options. important therapeutic Let's may that start with other Solutions we comprise the that reduced to where patients about of have complex oncology, It treatment Clinical clinical our areas believe total our see XX% full-service revenues. over businesses our and diseases, of limited and portion rare orphan of XX% disease impacts, as note essential is disease
teams we have of clinical are experienced least level April. into accessing are about allowing XX% investigative trends Our and inaccessible. at remainder, to activity, some sites, virtual continue although the these only seen XX% have XX% Of limitations
activities, comprise XX% monitoring which revenue. our full-service clinical impacts about primarily environment of this Overall,
Our clinical along job virtual in activities. other with to an a with leadership of monitoring, position incredible teams transitioning taking have done partnership remote ACRO,
expect additional access to remote XX% visits highly using our During a approach record of to monitoring to site we health follow-up to to requirements with dependent the provide convert capability XX% quarter, electronic upon tailored remote second platforms. site's a
has site areas. visits been least such While conduct site regions heavily China, access we certainly at live to have more in these Spain, impacted limited the some in and Italy continued as
have begun resuming slowly activities. were sites areas We that also see impacted in earlier these to
start-up clinical and In of have addition, enrollment delays patient our new in both experienced the clinical trials. teams
ensure to primarily driven our trials. significantly within short-term far of New patient patient continuity pause a April, enrollment down customers thus safety is by their taking some and in
stand it delays other recruitment and further ready less to staff. itself, file that continuing final of drive ethics master is billable are primarily in site start-up, are activity, are make activities. the we an precedes teams to to on that in our quickly on as we accelerating in final such we other regulatory, Although work move progress effort regions, activation trial work start-up reassigning seeing also activation. such In the the accelerating stages and clinical billable affected Therefore, study activities site
only impacts likely is within comprises systems. ability or contracted revenue have of biometrics, clinical FSP work from investigative processes, which upon units traditionally to studies of It business revenue. have performed an less particularly customers' FTE their about most service our remainder management most FSP but functions that are important our their XX% not note of of on The embedded that based services, activity. FSP revenues. remotely. access teams basis, impact their Therefore, disruptions about impacts and are existing like to to FSP clinical business, our which data monitoring shorter-term are XX% teams, These of safety, provider, sites, Our knowledge represents functional and similar given total seen on of teams
represent business phase on-site within portion our clinics clinical, business our total Our small requires X% represents the includes of that only the of staff. that early which revenue, operational about
host we're our to to have temporarily volunteers concerns, delay seeing safety clinics We of unable some related customers we back healthy and scaled due also of programs. groups are their because
business However, labs medicine operate. this to within bioanalytical our continue translational and
believe pharma support of base, where this provider integrated Commercial segment, position the essential customers. to an Note we Solutions with the from of revenue. currently portfolios products supporting where stable. Solutions Solutions locations its and chronic Deployment we types for and XX% product therapies, our teams Over XX% commercialization total XX% of of drives diverse of our revenue over nature are more stable. remained our has our our remain XX% about the of top setting In a of component Deployment XX business, the our of are physician care offices, component or volume call Solutions to category not is prescription health total current of customer Approximately represents care the hospital mix at Deployment will Moving concentration where outside our where in interact prevalent. we is field largest activity services the treatment COVID-XX that
on have to their field to they activities or our Solutions teams health Deployment faced our While virtual visit capabilities. limitations providers, quickly transitioned care enabled their of by HCPs, abilities have physically breadth the
interactions of transitioned Our travel collaborated and and to matched individual restrictions, have our were By environment. prior volume our teams level successfully March that in-person during office of our to virtual work-from-home given while center of HCPs activities customer each with train capacity XX% virtual mid-March, field a have learning into taking virtual nearly field effectively of the manage weekly consideration to the interactions occurring protocols. been COVID-XX. our mid-April, to By field team's solutions teams engagement preferred the reps
investments been omni-channel the our This enabled in capabilities last years. transition has X by over
are FSP Deployment customers' FTE that important on significant increased in interest commercial with with primarily models. they Solution We an to interest, demonstrate also are telephony, video our interest our teams note hybrid modified This evaluating also that and to is engage seeing which customer digital engagement customers, representatives, in center, multichannels business, to similar clinical contracted basis. our field in It tools. in is interest including enabled our along are
these notice In up termination contracts substantial XXX days. majority have of of to addition, the periods
see makes While and less open customers start-up positions. to begun new of this vulnerable programs an like them backfilling shorter-term delaying to of disruptions, FSP, the the also we have
of rather our our our of about communication not decisions. survey to buying as audiences than new data communications over therapies helping ever, to revenue, consumers A is information The completed important revenue. of and well which their continue to for business their meaningful stay and and of direct comprises to as or desire HCPs does now their X% HCPs business, majority is support stakeholders. The materials to confirm include than customers need key media recent communicate treatment more abreast other XXX we total
also seeing communications. has Solutions Like COVID-related of been around across the year-over-year growth business awards. are pipeline We opportunities impact in slower Deployment our new healthy primarily decisions our business,
Lastly, business already X% consulting about business our environment. operates virtual work in revenue. of a within represents our Commercial Solutions, This overall
by it has unaffected So been largely COVID-XX.
fact, of work a quarter going in durable is with our across care, Over all In than backlog saw and more evaluation largely mitigation in be quality medical the practices, we new consulting includes are strength and proven practice strategy first products to by where broader affairs strategy, of requirements. we compliance It health continued into the consulting includes XX% of and our customers the environment. risk market. business of areas robust which has April. regulatory practice given driven changing and which Further, strategy our launch commercial regulatory their help programs reevaluate also consulting
implemented have will have measures in reduction areas planned in and more which additional outline preservation needed, cash we detail. implement, all cost initiatives Jason if ready Finally, to and and
are excellent quality maintain any delivery, to We our customers. with the impacted benefit our of reaccelerate for commitment quickly activities measures these balancing and
comments let on turn over Now more to it me financial Jason? for performance. Jason our
